Below you’ll find a link to the filings and most recent 10Q. Search for key words, like nasal and funding.
You’ll find ZERO results for Nasal.
You’ll also find 1.) the company doesn’t have financial resources to advance Brilacidin into clinical trialsand 2.) the company plans to AVOID such investments of time and financial resources.
In the CEO’s own words from Management’s Plan of Operation, page 27, most recent 10Q filing - link below for context:
“Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully.” - IPIX CEO
“In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials.“ - IPIX CEO